特定感染微生物与髋关节假体周围感染治疗不良结局相关
该研究回顾2005至2015年因感染性部分或全髋关节置换术接受治疗的患者记录,分析特定微生物与治疗结局的关系。结果显示,MRSA、假单胞菌和变形杆菌与较低的感染无复发生存率、更多手术次数和更长住院时间均相关。微生物特异性结局信息可能有助于个体化医患沟通。
要点
- MRSA、假单胞菌和变形杆菌与髋关节假体周围感染治疗的全部3项不良结局相关。
- 感染某些微生物与额外1.13至2.58次手术相关。
- 感染特定微生物与额外8.56至24.54天住院时间相关。
核心结论
- MRSA、假单胞菌和变形杆菌与髋关节假体周围感染治疗中较低的感染无复发生存率、更多手术和更长住院时间全部3项结局相关。
- 微生物特异性结局信息可能有助于个体化医患关于髋关节假体周围感染预期治疗过程的讨论。
研究设计与样本
- 回顾性审查2005年至2015年间因感染性部分或全髋关节置换术接受治疗的所有患者的记录。
- 确定每位患者治疗过程的特征,包括基线特征、感染微生物、末次随访时感染状态、因感染所做手术及住院时间。
- 将单变量分析中与临床结局相关的基线特征和微生物纳入多变量结局模型。
主要发现
- 与其他微生物感染患者相比,假单胞菌、MRSA和变形杆菌感染患者的感染无复发生存率显著降低。
- 感染以下微生物与额外1.13至2.58次手术相关:甲氧西林敏感金黄色葡萄球菌、凝固酶阴性葡萄球菌、MRSA、假单胞菌、消化链球菌、克雷伯菌、念珠菌、类白喉菌、痤疮丙酸杆菌和变形杆菌。
- 特定微生物与额外8.56至24.54天住院时间相关:甲氧西林敏感金黄色葡萄球菌、凝固酶阴性葡萄球菌、变形杆菌、MRSA、肠球菌、假单胞菌、克雷伯菌、β溶血性链球菌和类白喉菌。
- 较高的合并症评分也与更长的住院时间相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic hip infection treatment remains a significant challenge for orthopedics. Some studies have suggested that methicillin resistance and gram-negative organism type are associated with increased treatment failure. The aim of this research is to determine if specific organisms were associated with poor outcomes in treatment for hip periprosthetic infection. METHODS: Records were reviewed of all patients between 2005 and 2015 who underwent treatment for infected partial or total hip arthroplasty. Characteristics of each patient's treatment course were determined including baseline characteristics, infecting organism(s), infection status at final follow-up, surgeries for infection, and time in hospital. Baseline characteristics and organisms that were associated with clinical outcomes in univariate analysis were incorporated into multivariable outcomes models. RESULTS: When compared with patients infected with other organism(s), patients infected with the following organisms had significantly decreased infection-free rates: Pseudomonas, methicillin-resistant Staphylococcus aureus (MRSA), and Proteus. Infection with certain organisms was associated with 1.13-2.58 additional surgeries: methicillin-sensitive S aureus, coagulase-negative Staphylococcus, MRSA, Pseudomonas, Peptostreptococcus, Klebsiella, Candida, diphtheroids, Propionibacterium acnes, and Proteus species. Specific organisms were associated with 8.56-24.54 additional days in hospital for infection: methicillin-sensitive S aureus, coagulase-negative Staphylococcus, Proteus, MRSA, Enterococcus, Pseudomonas, Klebsiella, beta-hemolytic Streptococcus, and diphtheroids. Higher comorbidity score was also associated with greater length of hospitalization. CONCLUSION: MRSA, Pseudomonas, and Proteus were associated with all 3 outcomes of lower infection-free rate, more surgery, and more time in hospital in treatment for hip periprosthetic infection. Organism-specific outcome information may help individualize patient-physician discussions about the expected course of treatment for hip periprosthetic infection.
引用
- Cunningham DJ, Kavolus JJ, Bolognesi MP, et al. Specific Infectious Organisms Associated With Poor Outcomes in Treatment for Hip Periprosthetic Infection. J Arthroplasty. 2017. PMID: 28222919. doi:10.1016/j.arth.2017.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。